terfenadine has been researched along with Adjuvant Arthritis in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, R | 1 |
| Chen, Y | 1 |
| Fu, W | 1 |
| Wang, S | 1 |
| Cui, Y | 1 |
| Zhao, X | 1 |
| Lei, ZN | 1 |
| Hettinghouse, A | 1 |
| Liu, J | 1 |
| Wang, C | 1 |
| Zhang, C | 1 |
| Bi, Y | 1 |
| Xiao, G | 1 |
| Chen, ZS | 1 |
| Liu, CJ | 1 |
1 other study available for terfenadine and Adjuvant Arthritis
| Article | Year |
|---|---|
Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis.
Topics: Animals; Arthritis, Experimental; Mice; Mice, Inbred DBA; Mice, Transgenic; Phospholipases A2, Cytos | 2019 |